| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |